• $1.5B
    Market Cap
  • 43.42%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
Research and Development Expense
-153.4M
+94.11%
-79.0M
N/A
Depreciation and Amortization Expense
-3.0M
N/A
N/A
N/A
Total Operating Expenses
177.5M
+88.25%
94.3M
N/A
Operating Profit
-177.5M
+88.25%
-94.3M
N/A
Interest Income
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
Income before Taxes
-177.5M
+88.25%
-94.3M
N/A
Income Taxes
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
-166.3M
+106.62%
-80.5M
N/A
Net Income from Continuing Operations Applicable to Common
-166.3M
+106.62%
-80.5M
N/A
Basic EPS and Net Income
-4.32
+68.75%
-2.56
N/A
Diluted EPS and Net Income
-4.32
+68.75%
-2.56
N/A
Basic Weighted Average Shares
38.5M
+22.22%
31.5M
N/A
Diluted Weighted Average Shares
38.5M
+22.22%
31.5M
N/A
Balance Sheet
Cash and Cash Equivalents
45.5M
-38.70%
74.3M
N/A
Short-Term Investments
267.3M
+84.88%
144.6M
N/A
Cash and Cash Equivalents and Short-Term Investments
312.8M
+42.93%
218.9M
N/A
Total Current Assets
332.9M
+46.66%
227.0M
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
Total Long-Term Assets
190,000
+50.79%
126,000
N/A
Total Assets
333.2M
+21.18%
274.9M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
Total Current Liabilities
25.9M
+50.20%
17.3M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
14,000
0.00%
14,000
N/A
Total Liabilities
25.9M
+50.08%
17.3M
N/A
Retained Earnings
-404.6M
+69.78%
-238.3M
N/A
Total Stockholders Equity
307.2M
+19.24%
257.7M
N/A
Total Shares Outstanding
42.5M
+25.95%
33.7M
N/A
Cash Flow
Cash from Operating Activities
-160.6M
+128.72%
-70.2M
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
Cash from Investing Activities
-71.2M
-62.99%
-192.5M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
203.1M
+8.83%
186.6M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
Return on Assets
-54.70%
N/A
N/A
N/A
Return on Equity
-58.88%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
Current Ratio
12.83
N/A
N/A
N/A
Cash Ratio
1.76
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow